These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34332233)

  • 1. Discovery of 4-benzyloxy and 4-(2-phenylethoxy) chalcone fibrate hybrids as novel PPARα agonists with anti-hyperlipidemic and antioxidant activities: Design, synthesis and in vitro/in vivo biological evaluation.
    Hassan RM; Aboutabl ME; Bozzi M; El-Behairy MF; El Kerdawy AM; Sampaolese B; Desiderio C; Vincenzoni F; Sciandra F; Ghannam IAY
    Bioorg Chem; 2021 Oct; 115():105170. PubMed ID: 34332233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and synthesis of novel quinazolinone-based fibrates as PPARα agonists with antihyperlipidemic activity.
    Hassan RM; Ali IH; Abdel-Maksoud MS; Abdallah HMI; El Kerdawy AM; Sciandra F; Ghannam IAY
    Arch Pharm (Weinheim); 2022 Mar; 355(3):e2100399. PubMed ID: 34958132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel structural class of coumarin-chalcone fibrates as PPARα/γ agonists with potent antioxidant activities: Design, synthesis, biological evaluation and molecular docking studies.
    Niu H; Wang W; Li J; Lei Y; Zhao Y; Yang W; Zhao C; Lin B; Song S; Wang S
    Eur J Med Chem; 2017 Sep; 138():212-220. PubMed ID: 28667876
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Fibrates as Important Scaffolds in Medicinal Chemistry.
    Giampietro L; Ammazzalorso A; Amoroso R; De Filippis B
    ChemMedChem; 2019 Jun; 14(11):1051-1066. PubMed ID: 30957432
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural simplification and bioisostere principle lead to Bis-benzodioxole-fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
    Xie Y; Liu J; Shi Y; Wang B; Wang X; Wang W; Sun M; Xu X; Cheng L; He S
    Bioorg Chem; 2021 Dec; 117():105454. PubMed ID: 34740054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of novel indole-chalcone fibrates as lipid lowering agents.
    Sashidhara KV; Dodda RP; Sonkar R; Palnati GR; Bhatia G
    Eur J Med Chem; 2014 Jun; 81():499-509. PubMed ID: 24871900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of amide based fibrates as possible antidyslipidemic and antioxidant agents.
    Sashidhara KV; Palnati GR; Dodda RP; Sonkar R; Khanna AK; Bhatia G
    Eur J Med Chem; 2012 Nov; 57():302-10. PubMed ID: 23078966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design, synthesis and evaluation of 5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thione-Based fibrates as potential hypolipidemic and hepatoprotective agents.
    Shao L; Bai Y; Wang Q; Chen Z; Xie Y; Bian X
    Bioorg Med Chem Lett; 2019 Dec; 29(23):126723. PubMed ID: 31624042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-(4-Hydroxyphenyl)-3H-1,2-dithiole-3-thione-based fibrates as potential hypolipidemic and hepatoprotective agents.
    Chen ZZ; Xie YD; Shao LH; Wang QT; Xu YH; Bian XL
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3787-3792. PubMed ID: 30337230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1,3-Benzodioxole-based fibrate derivatives as potential hypolipidemic and hepatoprotective agents.
    Xie YD; Xu YH; Liu JP; Wang B; Shi YH; Wang W; Wang XP; Sun M; Xu XY; Bian XL
    Bioorg Med Chem Lett; 2021 Jul; 43():127898. PubMed ID: 33684440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Phenoxazinones as potent agonist of PPAR-α: design, synthesis, molecular docking and in vivo studies.
    Ugwu DI; Okoro UC; Mishra NK; Okafor SN
    Lipids Health Dis; 2018 May; 17(1):120. PubMed ID: 29789011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotriglyceridemic effects of apple polyphenols extract via up-regulation of lipoprotein lipase in triton WR-1339-induced mice.
    Yao N; He RR; Zeng XH; Huang XJ; Du TL; Cui JC; Hiroshi K
    Chin J Integr Med; 2014 Jan; 20(1):31-5. PubMed ID: 23001493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The human liver fatty acid binding protein T94A variant alters the structure, stability, and interaction with fibrates.
    Martin GG; McIntosh AL; Huang H; Gupta S; Atshaves BP; Landrock KK; Landrock D; Kier AB; Schroeder F
    Biochemistry; 2013 Dec; 52(51):9347-57. PubMed ID: 24299557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and in Vivo Lipid-Lowering Activity of Novel Imidazoles-5-carboxamide Derivatives in Triton-WR-1339-Induced Hyperlipidemic Wistar Rats.
    Jasim SH; Abu Sheikha GM; Abuzaid HM; Al-Qirim TM; Shattat GF; Sabbah DA; Ata SA; Ala SA; Aboumair MS; Sweidan KA; Bkhaitan MM
    Chem Pharm Bull (Tokyo); 2018; 66(10):953-958. PubMed ID: 30270241
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indole-based fibrates as potential hypolipidemic and antiobesity agents.
    Sashidhara KV; Kumar M; Sonkar R; Singh BS; Khanna AK; Bhatia G
    J Med Chem; 2012 Mar; 55(6):2769-79. PubMed ID: 22339404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-hyperlipidemic properties of CM108 (a flavone derivative) in vitro and in vivo.
    Guo L; Hu WR; Lian JH; Ji W; Deng T; Qian M; Gong BQ
    Eur J Pharmacol; 2006 Dec; 551(1-3):80-6. PubMed ID: 17026988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hybrid benzofuran-bisindole derivatives: new prototypes with promising anti-hyperlipidemic activities.
    Sashidhara KV; Modukuri RK; Sonkar R; Rao KB; Bhatia G
    Eur J Med Chem; 2013 Oct; 68():38-46. PubMed ID: 23954239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypolipidemic and antioxidant activity of ethanolic extract of Symplocos racemosa Roxb. in hyperlipidemic rats: an evidence of participation of oxidative stress in hyperlipidemia.
    Durkar AM; Patil RR; Naik SR
    Indian J Exp Biol; 2014 Jan; 52(1):36-45. PubMed ID: 24617014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel PPAR pan agonist, ZBH ameliorates hyperlipidemia and insulin resistance in high fat diet induced hyperlipidemic hamster.
    Chen W; Fan S; Xie X; Xue N; Jin X; Wang L
    PLoS One; 2014; 9(4):e96056. PubMed ID: 24759758
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
    Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.